Background
==========

The presence of multiple coexistent chronic diseases is increasingly recognized as a major public health challenge of modern societies \[[@B1],[@B2]\]. Challenges include optimalization of individuals' health despite multimorbidity and the organisation and provision of health care for multimorbid patients. A first step in meeting these challenges is to provide insight into the size of the population suffering from multimorbidity, and the type of multimorbidity. Several studies on these figures are now available, showing high prevalences of multimorbidity \[[@B3]-[@B7]\]. Until now however, the distribution and combination of specific diseases received very little attention \[[@B8]\]. Health care needs of patients with multiple chronic conditions not only depend on the number but also, and maybe even more so, on the type of co-occurring diseases. With the ageing population and the accompanying rise in multimorbidity, the burden of chronically ill on health service capacity and costs is high \[[@B9]\] and is expected to rise in the future. Insight into combinations of diseases which often co-occur may assist in planning and improving (the organization of) health care services.

In this paper we analyze the prevalence of multimorbidity of chronic diseases by age and sex and the clustering of chronic diseases on the basis of electronic medical records in a representative sample of Dutch general practices. For a selection of 10 specific diseases we also present a detailed picture of the comorbidity, i.e. the type and prevalence of additional diseases among that specific disease.

Methods
=======

Study design & participants
---------------------------

We used a longitudinal dataset of electronic medical records of over 350,000 patients in a representative sample of 92 general practices that participate in the Netherlands Information Network of General Practice (LINH), covering circa 2% of the total Dutch population \[[@B10]\]. General practices within this network are evenly distributed across the Netherlands. The listed population and the general practices are representative for the Dutch population and the Dutch general practitioners, respectively. In the Netherlands, all individuals are obligatory listed in a general practice, with exception of a small, very old part of the Dutch population in nursing homes. Therefore, the listed population can be used as the denominator in population based epidemiological studies. The prevalence of multimorbidity was analysed using LINH data from 2002 to 2008. LINH is registered with the Dutch Data Protection Authority; data are handled according to the data protection guidelines of the authority. According to Dutch legislation, studies using this kind of observational data do not require medical ethical approval.

Dataset
-------

LINH includes routinely recorded data on consultations, including drug prescriptions and referrals. Diagnostic codes were recorded with consultations, drug prescriptions, and referrals, according to the International Classification of Primary Care (ICPC) \[[@B11]\]. Episodes of care were constructed and included all patients contacts and drug prescriptions pertaining to a specific health problem \[[@B12]\]. Thus two consultations for the same health problem are grouped into one episode of care. Consider, for instance, a patient who visits the general practitioner with a chronic cough, and a few months later the same patient is diagnosed with COPD. Most likely, both diagnoses refer to the same health problem and to avoid double counting the two diagnoses were grouped into one episode of care named COPD. Another example is a patient with symptoms of breathlessness and a diagnosis of heart failure a few weeks later, these health problems were grouped into one episode of heart failure. These episodes were constructed by EPICON, an algorithm to group ICPC-coded contact records from electronic medical records in general practice into episodes of care \[[@B13],[@B14]\].

For prevalence calculations the data from general practices should meet standards for completeness, i.e. for each general practice the percentage of valid ICPC codes should be 60% or more and the registration of morbidity and prescriptions must have occurred continuously over each year \[[@B10]\].

Multimorbidity and comobidity
-----------------------------

Multimorbidity is defined as the co-occurrence of two or more chronic diseases within one person in a specific period of time \[[@B15]\]. Comorbidity refers to the presence of at least one extra chronic disease along with a chronic disease of interest \[[@B16]\]. Chronic diseases are defined as irreversible conditions without complete recovery or relatively long-lasting conditions. Diseases were selected based on high prevalence and a chronic and severe character from a standard list of chronic conditions for primary care \[[@B17]\]. This resulted in 29 chronic diseases, presented with ICPC codes in Table[1](#T1){ref-type="table"}\[[@B17]\]. Comorbidity was explored for 10 chronic diseases which are prevalent among older patients: diabetes mellitus, coronary heart disease, osteoarthritis, chronic obstructive pulmonary disease (COPD), chronic neck- or back disorders, cancer, stroke, depression, heart failure, and anxiety disorders.

###### 

Selection of 29 chronic diseases with ICPC-1 codes

  **Chronic disease**                     **ICPC-1 code**
  --------------------------------------- ---------------------------------------------------------------------------------------------------------
  Tuberculosis                            A70
  HIV/AIDS                                B90
  Cancer                                  A79, B72, B73, D74, D75, D77, L71, N74, R84, R85, S77, T71, U75, U76, U77, W72, X75, X76, X77, Y77, Y78
  Gastric or duodenal ulcer               D85, D86
  Chronic enteritis/colitis ulcerosa      D94
  Visual disorder                         F83, F84, F92, F93, F94
  Hearing disorder                        H84, H85
  Congenital cardiovascular anomaly       K73
  Coronary heart disease                  K74, K75, K76
  Heart failure                           K77
  Stroke (including TIA)                  K89, K90
  Chronic back or neck disorder           L83, L84, L85, L86
  Rheumatoid arthritis                    L88
  Osteoarthritis                          L89, L90, L91
  Osteoporosis                            L95
  Congenital neurological anomaly         N85
  Multiple sclerosis                      N86
  Parkinson's disease                     N87
  Epilepsy                                N88
  Chronic alcohol abuse                   P15
  Dementia                                P70
  Schizophrenia                           P72
  Anxiety disorder, neurosis, PTSS        P74, P79
  Depressive disorder                     P76
  Mental retardation                      P85
  Chronic obstructive pulmonary disease   R91, R95
  Asthma                                  R96
  Anorexia                                T06
  Diabetes mellitus                       T90

The selection of chronic diseases is based on 'Defining chronic conditions for primary care using ICPC-2: supplementary data\'.\[[@B17]\] ICPC-2 codes are encoded into ICPC-1 codes.

Prevalence
----------

Given that diagnoses are recorded based on patient contacts, the prevalence of some chronic diseases is underestimated when medical records from one year are used. In general, patients with diabetes or COPD visit their general practitioner frequently throughout a year but patients with osteoarthritis or asthma for example visit their general practitioner infrequently, sometimes even less than once a year. Therefore, only patients registered for a minimum period of 3 consecutive years in a general practice within the LINH network were selected.

Analyses
--------

The selection of patients registered for a minimum period of 3 consecutive years resulted in a study population of 212,902 patients registered with 59 general practices.

Sex and age standardization was applied in all prevalence estimates to account for differences with the Dutch population in 2008 (<http://statline.cbs.nl>). The prevalence of chronic diseases and multimorbidity was defined as the number of patients with one or more diseases divided by the total number of 212,902 registered patients. In addition, prevalence estimates were stratified according to sex and age groups. To determine prevalence estimates it was assumed that a chronic disease, once recorded, remains prevalent during all follow-up years in the registration (recovery is not possible).

Analyses for clustering and comorbidity were restricted to 52,014 patients of 55 years and older. If diseases are completely independent of one another, they can be expected to co-occur at a rate which equals the product of the prevalence rates of the separate diseases \[[@B5]\]. For some pairs of diseases, the rate of co-occurrence may be higher than expected, which is referred to as disease clustering \[[@B18]\]. Clustering of chronic diseases is determined by the ratio of the observed prevalence rate and the expected prevalence rate of the pair of diseases. Logistic regression analyses adjusted for sex and age were used to investigate disease clustering.

For each of the 10 chronic diseases the proportion patients without comorbidity and those with 1, 2, 3, and 4 or more comorbid diseases was calculated. Finally, the five most prevalent comorbid chronic diseases (from 28 other diseases) were determined for the 10 specific diseases.

All analyses were performed in SAS version 9.2 (SAS Institute, Cary, North Carolina, USA).

Results
=======

One-third of all registered patients had at least one chronic disease out of 29 chronic diseases (all ages) and about 13% had multimorbidity (Table[2](#T2){ref-type="table"}). The prevalence rate of chronic diseases and multimorbidity is higher for women and higher age groups. Of patients of 75 years and older 84% had a chronic disease and 59% had more than one chronic disease. In total, 37% of all patients of 55 years and older was known with multimorbidity.

###### 

Prevalence rates of patients with chronic diseases and patients with multimorbidity according to sex and age, LINH 2002-2008

                **N**     **Prevalence rate of patients with chronic diseases (%)\***   **Prevalence rate of multimorbid patients (%)\***
  ------------- --------- ------------------------------------------------------------- ---------------------------------------------------
  Total         212,902   33.7%                                                         12.9%
  Men           105,547   30.7%                                                         10.9%
  Women         107,355   36.6%                                                         15.0%
  0-14 years    38,944    12.6%                                                         0.6%
  15-24 years   26,718    15.2%                                                         2.0%
  25-54 years   95,226    30.0%                                                         8.1%
  55-64 years   22,592    52.9%                                                         22.7%
  65-74 years   17,465    70.0%                                                         39.1%
  74+ years     11,957    83.5%                                                         59.2%

\* According to the selection of 29 chronic diseases in Table[1](#T1){ref-type="table"}.

The prevalence estimates for pairs of chronic diseases in the population of 55 years and older are presented in Table[3](#T3){ref-type="table"}. The prevalence of co-occuring diabetes and coronary heart disease was 3.6% for example, and COPD and osteoarthritis co-occur in 1.7% of the patients. Most odds ratios are significantly higher than 1.0, indicating that almost all pairs of chronic diseases co-occur more frequently than expected on basis of statistical independency of diseases. The highest odds ratios were found for the disease pairs depression and anxiety disorder, coronary heart disease and heart failure, and COPD and heart failure.

###### 

**Prevalence (P) co-occuring chronic diseases (%)**^**1**^**and the sex and age adjusted odds ratio (OR) for clustering for patients of 55 years and older**^**2**^**, LINH 2002--2008**

                                  **Coronary heart disease**   **Osteoarthritis**   **COPD**   **Chronic neck or back disorder**   **Cancer**   **Stroke**   **Depression**   **Heart failure**   **Anxiety disorder**                                                           
  ------------------------------- ---------------------------- -------------------- ---------- ----------------------------------- ------------ ------------ ---------------- ------------------- ---------------------- ------- ----- ------- ----- ------- ----- ------- ----- -------
  Diabetes mellitus               3.6                          1.9\*^3^             2.8        1.1\*                               2.1          1.3\*        2.5              1.3\*               1.9                    1.1     1.9   1.6\*   1.4   1.2\*   2.2   1.7\*   0.5   1.1
  Coronary heart disease                                                            2.5        1.3\*                               2.2          1.6\*        2.3              1.6\*               1.8                    1.2\*   1.5   1.3\*   1.3   1.5\*   2.8   3.7\*   0.4   1.5\*
  Osteoarthritis                                                                                                                   1.7          1.2\*        2.8              2.0\*               1.7                    1.1\*   1.2   1.0\*   1.4   1.4\*   1.6   1.3\*   0.4   1.1
  COPD                                                                                                                                                       1.5              1.4\*               1.4                    1.3\*   1.0   1.3\*   1.0   1.7\*   1.9   3.4\*   0.4   1.7\*
  Chronic neck or back disorder                                                                                                                                                                   1.4                    1.2\*   1.0   1.3\*   1.2   1.5\*   0.9   1.2\*   0.5   1.4\*
  Cancer                                                                                                                                                                                                                         0.9   1.0     0.9   1.4\*   1.2   1.3\*   0.3   1.4\*
  Stroke                                                                                                                                                                                                                                       0.8   1.6\*   1.2   1.5\*   0.2   1.3\*
  Depression                                                                                                                                                                                                                                                 0.7   1.5\*   0.8   5.9\*
  Heart failure                                                                                                                                                                                                                                                            0.2   1.5\*

^1^Prevalence estimates are standardized according to the age and sex distribution in the Dutch population in 2008.

^2^ The odds ratio represents the 'probability' for co-occurrence of 2 chronic diseases. Two chronic diseases co-occur more frequent than would be expected on basis of independency if the odds ratio is larger than 1.0 and the 95% confidence interval does not include 1.0.

^3^ The prevalence of comorbidity of diabetes mellitus and coronary heart disease is 3.6%. Diabetes mellitus and coronary heart disease co-occur significantly more frequent than expected on basis of independency, with an odds ratio of 1.9.

\* Co-occurrence of diseases occurred more frequent than expected on basis of independency (p \< 0.05).

Over 70% of those with one of the selected 10 chronic diseases had also one or more other chronic diseases (comorbidity). The highest proportion of comorbidity is shown for heart failure, of all patients with heart failure 92% had at least one extra chronic disease (Figure[1](#F1){ref-type="fig"}). About a quarter of the patients with heart failure had one extra disease, 23% two extra diseases, 21% three extra diseases, and 22% had four or more extra chronic diseases.

![Prevalence of 10 chronic diseases and comorbidity (%) among patients of 55 years and older.](1471-2458-12-715-1){#F1}

Diabetes mellitus, osteoarthritis, and coronary heart disease were the most prevalent co-occuring diseases for all 10 diseases (Table[4](#T4){ref-type="table"}). From all patients with cancer and one or more extra diseases, 26% was recorded with diabetes mellitus, 24% with coronary heart disease, 23% with osteoarthritis, 19% with chronic neck- or back disorders, and 18% with COPD. One-third of those with cancer and comorbidity had only diseases included in the top-5 comorbid diseases for cancer, the other patients (two-thirds) had at least one disease that was not included in the top-5 comorbid diseases for cancer. Similar numbers were shown for the 9 other specific diseases (Table[4](#T4){ref-type="table"}): about 30% of the patients with comorbidity had only diseases included in the top-5 whereas 70% had one or more diseases not included in the top-5.

###### 

Top 5 of most prevalent comorbidity for 10 chronic diseases (first column) and prevalence of co-occuring diseases among all patients of 55 years and older with the specific chronic disease and comorbidity

  **Chronic disease**                  **Comorbidity top 5 and prevalence**  **Contribution of top 5 to all comorbidity with the specific chronic disease\***                                                                                                                                             
  ----------------------------------- -------------------------------------- ---------------------------------------------------------------------------------- ------------------------ ------- ------------------------------- ------- ------------------------------- ------- ---------------- ------- -------
  **Diabetes mellitus**                       Coronary heart disease         30.0%                                                                                        Osteoarthritis 22.7%     Chronic neck or back disorder 20.3%                     Heart failure 18.1%               COPD 17.2%    31.5%
  **Coronary heart disease**                    Diabetes mellitus            33.5%                                                                                         Heart failure 25.5%                    Osteoarthritis 23.0%     Chronic neck or back disorder 20.8%             Cancer 16.7%    32.8%
  **Osteoarthritis**                      Chronic neck or back disorder      26.8%                                                                                     Diabetes mellitus 26.0%            Coronary heart disease 23.6%                   Visual disorder 16.4%             Cancer 16.0%    33.5%
  **COPD**                                            Asthma                 32.4%                                                                                Coronary heart disease 27.4%                 Diabetes mellitus 25.8%                     Heart failure 24.0%     Osteoarthritis 20.5%    29.9%
  **Chronic neck or back disorder**               Osteoarthritis             31.5%                                                                                     Diabetes mellitus 27.3%            Coronary heart disease 25.2%                              COPD 17.0%             Cancer 15.5%    35.8%
  **Cancer**                                    Diabetes mellitus            25.6%                                                                                Coronary heart disease 24.4%                    Osteoarthritis 22.8%     Chronic neck or back disorder 18.8%               COPD 18.3%    33.1%
  **Stroke**                                    Diabetes mellitus            32.4%                                                                                Coronary heart disease 26.0%                    Osteoarthritis 21.0%                     Heart failure 20.2%               COPD 17.5%    27.8%
  **Depression**                                  Osteoarthritis             24.7%                                                                                     Diabetes mellitus 24.6%            Coronary heart disease 22.8%     Chronic neck or back disorder 22.3%               COPD 18.0%    26.4%
  **Heart failure**                           Coronary heart disease         42.0%                                                                                     Diabetes mellitus 33.3%                              COPD 29.4%                    Osteoarthritis 24.5%             Stroke 18.0%    30.4%
  **Anxiety disorder**                              Depression               38.0%                                                                                     Diabetes mellitus 22.3%     Chronic neck or back disorder 22.2%            Coronary heart disease 20.7%     Osteoarthritis 19.8%    31.4%

^1^ Prevalence is determined by dividing the number of patients with a specific combination of co-occuring diseases through the number of patients with the specific chronic disease and 1 or more other chronic diseases. Prevalence estimates are standardized according to the sex and age distribution in the Dutch population in 2008.

\* According to the selection of 29 chronic diseases in Table[1](#T1){ref-type="table"}.

Discussion
==========

Our analyses show that multimorbidity is common, especially among older persons, and that among those with a chronic disease over two thirds has other comorbidities. A more detailed look at the combinations of diseases showed a wide variety in multimorbidity. We observed that all chronic diseases tend to cluster, i.e. most disease pairs co-occur more often than expected by chance. Furthermore, the top-5 of co-occurring chronic diseases represents only a minor proportion of the comorbidity: all diseases co-occur together. These findings may have important consequences since the organization and funding of health care is organized by disease-specific programs in many countries. Such disease-specific approaches do not match the reality of most people with a chronic disease.

Strengths and weaknesses of the study
-------------------------------------

Primary care registries represent an interesting source to describe multimorbidity of chronic diseases because often most health problems are known and recorded by the general practitioner, especially in countries as the Netherlands where general practice is the entry point for health care and general practitioners act as gatekeeper for secondary care. Analyzing multimorbidity among general practice patients can be used for different research questions \[[@B3],[@B4],[@B19],[@B20]\] but ideally we need to know the underlying population or epidemiological denominator. Strength of general practice registries in the Netherlands is that almost everybody is registered within a general practice. Hence, it is possible to use morbidity data from the general practice registries to describe morbidity of the general population.

In addition, use of long-term registration data of a country-wide network of general practices for the analyses on multimorbidity has several advantages, like the distribution of the general practices over the Netherlands, the relatively long registration period, and the standardized registration procedures. A general strength of general practice medical records compared to self-reported data is the availability of diagnosed chronic diseases. A disadvantage is that diseases for which patients do not consult a general practitioner are not in the general practitioners' medical record system. In addition, the small group of elderly in nursing homes, usually having more than one chronic disease, are generally not registered within a general practice. Owing to these exclusions the prevalence of chronic diseases in the general population may be underestimated based on general practice registrations. Underdiagnosis and underreporting of health problems like depression may also lead to underestimation of the prevalence of multimorbidity.

Length of follow-up in a registration affects the extent and the reliability of multimorbidity estimates \[[@B21]\]. The frequency of general practitioner consultations for some diseases, such as osteoarthritis, are even less than once a year. The prevalence of those diseases is underestimated in a registration with a one-year follow-up, therefore the minimum patient follow-up in our study was three years. With a longer follow-up period selection may play a role since patients move away and general practices drop out from the registration.

Apparently, the prevalence of multimorbidity in this study is completely determined by the selection of 29 chronic diseases. Generally speaking, the more chronic conditions are included the higher prevalence rates of multimorbidity will be found. We presume that an important part of chronic morbidity is included in our selection of diseases. By counting the number of chronic diseases we did not take into account any differences in the severity of diseases \[[@B22]\]. When interpreting the results of our and similar studies that are based on general practice registrations, it should be noticed that the varying consequences of diseases on patients' physical and mental functioning, disability and independency are not considered \[[@B8],[@B23]\].

Comparison with literature
--------------------------

Registry characteristics affect the prevalence and nature of multimorbidity, especially the selection and definition of diseases affect the actual prevalence rates \[[@B21],[@B24]\]. This limits comparisons with other studies, even those based on general practice registries. However, the general patterns we found are similar to those of other studies. First, multimorbidity being rather the rule than the exception and prevalences increasing with age but also found at younger age \[[@B3]-[@B8],[@B25]-[@B27]\]. Second, clustering of diseases is commonly found in all recent studies on multimorbidity of (chronic) diseases \[[@B5],[@B28]-[@B32]\]. Third, the most prevalent diseases like heart disease, diabetes and osteoarthritis end up high in every multimorbidity rank \[[@B4],[@B29]\]. Most studies showed hypertension, obesity and hyperlipidemia to rank high in prevalence when it was defined as a chronic disease \[[@B21],[@B28],[@B29]\]. To our opinion these are chronic *conditions* that increase the risk on chronic disease but are not *diseases*, we therefore did not include these in our analyses. Fourth, a majority of persons with one chronic disease also have at least one (and often more) other disease and these are not limited to a few common diseases, these can be any disease \[[@B6],[@B28],[@B29]\]. While a descriptive approach was used in our analyses and others \[[@B6],[@B29]\] few other studies performed cluster analyses to identify comorbidity patterns \[[@B28],[@B30]-[@B32]\]. These studies identified 3 to 6 clusters of diseases and most revealed a cluster with vascular conditions and a cluster with mental diseases along with pain \[[@B28],[@B30],[@B32]\]. We focused on common co-occuring conditions and our findings indicate a wide variety of co-occuring conditions since only 30% of the comorbidity spectrum can be attributed to the 5 most common comorbidities. In line with this, van den Bussche described that combinations of the six most prevalent chronic conditions span only 42% of the comorbidity spectrum \[[@B29]\].

Implications of the study
-------------------------

A substantial proportion of the older population being characterized by multimorbidity of chronic diseases requires reconsiderations of medical research as well as the organization of care. Most research and clinical practice are based on a single disease paradigm, which may not be appropriate for patients with multiple complex health problems \[[@B33],[@B34]\]. Studies investigating the (cost-)effectiveness of new treatments commonly exclude patients with multimorbidity. Findings from these studies have a very limited reach since multimorbidity affects the majority of the aged. There is thus a clear need to shift research from disease-specific treatments and patients with single diseases to research which takes into account multimorbidity or is explicitly focused on patients with multimorbidity \[[@B35]\].

Multimorbidity leads to complex care through the use of different treatment strategies and the involvement of various health care professionals, which may lead to opposing advices (counseling) or medications \[[@B36]\]. Due to fragmented expertise and focus by different care providers, patients preferences, expectancies, values and needs regarding their daily life are often overlooked \[[@B37]\]. Patients' main priorities are usually an adequate quality of life and appropriate daily functioning in addition to the improvement of disease-specific health problems.

Currently, disease management programs are implemented worldwide in order to enhance quality and continuity of care for the chronically ill \[[@B38],[@B39]\]. These programs are characterized by a patient-centered approach of coordinated multiple healthcare interventions that structure chronic care to a specific patient group \[[@B39],[@B40]\]. However, participating in multiple single-disease oriented programs in combination with regular primary care, may lead to fragmented care. In designing these programs insufficient attention is paid to multimorbid conditions. Multimorbid patients are therefore at risk for suboptimal treatment, unsafe care, inefficient use of health care services, unnecessary costs and consequently run higher risks for adverse events \[[@B41]\]. Case management is a potential model which might counteract fragmented care for multimorbid patients. It is an individualized care program which coordinates all care involved for patients enrolled in different single-disease management programs, who have to adhere to various treatment protocols. It draws on evidence-based optimal care for systematically managing all existing conditions in a patient, and is tailored to the individual patients' preferences \[[@B42]-[@B44]\].

The finding that multimorbidity cannot be captured with a few common combinations of diseases represents a challenge for disease-specific treatment as well as disease-specific disease management programs and rises the question for which patient group case management should be implemented. Given the enormous variety in multimorbidity, we need more knowledge about the co-occurring conditions that are leading to a high need for care, a major decline in quality of life, and/or an increase in functional limitations.

Conclusion
==========

Multimorbidity is common at all ages and cannot be captured by a few common combinations of diseases.
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